Kashi Javaherian

Title: Kashi Javaherian: Innovator in Fibrosis Treatment

Introduction

Kashi Javaherian is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment and diagnosis of fibrosis and related diseases. With a total of 5 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on "Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases." This invention involves a protein oligomer that comprises at least two NC-monomers of collagen 18, endostatin domains of collagen 18, or N-terminal peptides of the collagen 18 endostatin domain. It is designed for use in treating, ameliorating, or preventing fibrosis or related diseases, including vascular endothelial growth factor (VEGF)-related diseases and matrix metalloproteinase (MMP)-related diseases. Another significant patent is for "Anti-angiogenic peptides for treating or preventing endometriosis." This invention includes peptides from the N-terminal of endostatin proteins and methods for using these pharmaceutical compositions to treat or prevent endometriosis in subjects.

Career Highlights

Throughout his career, Kashi has worked with reputable organizations such as Repligen Corporation and Children's Medical Center Corporation. His experience in these institutions has allowed him to develop innovative solutions to complex medical challenges.

Collaborations

Kashi has collaborated with notable individuals in his field, including Gary S Gray and Jerry Carson. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kashi Javaherian's work in the field of fibrosis treatment showcases his dedication to innovation and medical advancement. His patents reflect a commitment to improving health outcomes for individuals affected by fibrosis and related diseases.